查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614185

栓塞预防设备市场：按设备类型、应用程式和最终用户划分 - 2025-2030 年全球预测

Embolic Protection Devices Market by Device Type (Distal Filters, Distal Occlusion Devices, Proximal Occlusion Devices), Application (Cardiovascular Procedures, Neurovascular Procedures), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，栓塞防护设备市场价值为17.2亿美元，预计到2024年将达到18.6亿美元，复合年增长率为8.11%，到2030年将达到29.8亿美元。

栓塞防护装置（EPD）是一种介入装置，旨在捕捉和清除经经皮冠状动脉介入治疗（PCI）和经导管主动脉瓣置换术（TAVR）等手术过程中脱落的碎片，在心血管手术中发挥着重要作用。这种需求源自于预防栓塞的需要，栓塞是一种可能导致中风和心肌梗塞的严重併发症。这些设备适用于各种手术，主要是心血管系统，最终用途市场扩展到医院、心臟中心和门诊手术中心。 EPD市场的成长受到心血管疾病盛行率的增加和对微创手术技术日益偏好的影响。此外，设备设计的技术进步，例如病患安全性和手术疗效的提高，正在进一步推动市场。一个显着的机会在于新兴市场，这些市场的医疗基础设施十分开拓，熟练专业人员的数量不断增加，患者对心血管健康的认识不断提高。然而，市场面临着高成本、监管障碍以及需要熟练人员有效操作这些先进技术等限制。挑战包括激烈的竞争和阻碍市场渗透的报销问题。开发工作应专注于整合人工智慧和机器学习，以改善设备功能和患者治疗效果，以及创建可重复使用、经济高效的设备并提高可访问性。您还可以透过探索与研究机构的伙伴关係和合作来培养创新解决方案。 EPD 市场的本质是动态的，受到不断的技术进步和不断变化的临床需求的驱动。能够适应这些变化并专注于以患者为中心的解决方案，同时应对监管和成本限制的公司可以巩固其市场地位并推动业务显着成长。

主要市场统计
基准年[2023] 17.2亿美元
预测年份 [2024] 18.6亿美元
预测年份 [2030] 29.8亿美元
复合年增长率（%） 8.11%

市场动态：揭示快速发展的栓塞预防设备市场的关键市场洞察

供需的动态交互作用正在改变栓塞防护设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 心血管疾病和心臟病的增加
    • 政府不断采取措施提高心臟健康意识并改善心臟病的诊断
    • 扩大手术中心，临床参与栓塞预防装置的研究
  • 市场限制因素
    • 发生栓塞防护装置或系统的产品召回
  • 市场机会
    • 持续创新，提升栓塞防护装置的功能、安全性和效率
    • 栓塞防护装置审批的监管核准和支持
  • 市场问题
    • 栓塞防护装置的性能问题与技术复杂性

波特的五力：驾驭栓塞预防设备市场的策略工具

波特的五力架构是了解栓塞预防设备市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解栓塞预防设备市场的外部影响

外部宏观环境因素在塑造栓塞防护设备市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解栓塞预防设备市场的竞争格局

对栓塞预防设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：栓塞预防设备市场供应商的绩效评估

FPNV定位矩阵是评估栓塞防护器械市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製栓塞预防设备市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对栓塞预防设备市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病和心臟病的发生率增加
      • 政府努力提高人们对心臟健康的认识并改善心臟病的诊断
      • 扩大外科中心和临床参与栓塞预防装置的研究
    • 抑制因素
      • 发生栓塞防护装置或系统的产品召回
    • 机会
      • 持续创新，提升栓塞防护装置的功能、安全性和效率
      • 栓塞防护装置审批的监管核准和支持
    • 任务
      • 栓塞防护装置的性能问题与技术复杂性
  • 市场区隔分析
    • 设备类型：灵活性、有效性和微创性推动远端过滤器的采用增加
    • 应用：对栓塞防护装置的需求不断增长，以管理大容量心血管干预和手术
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章栓塞预防设备市场：依设备类型

  • 介绍
  • 远端过滤器
  • 远端阻塞设备
  • 近端阻塞设备

第七章栓塞预防设备市场：依应用分类

  • 介绍
  • 心血管外科
  • 神经血管手术

第八章栓塞预防设备市场：依最终使用者分类

  • 介绍
  • 门诊手术中心
  • 医院
  • 专科诊所

第九章北美及南美栓塞预防设备市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区栓塞预防设备市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的栓塞预防设备市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Protembis GmbH 获得 3,247 万美元 B 轮资金筹措，加速 PROTEMBO 脑保护测试
    • AorticLab 创新 FLOWer 栓塞保护装置获得 CE 标誌核准
    • FDA核准F2 脑保护系统研究，EnCompass Technologies 达到里程碑
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Balton Sp. z oo
  • Boston Scientific Corporation
  • Contego Medical, Inc.
  • Cook Group Incorporated
  • Cordis
  • Edwards Lifesciences Corporation
  • Emboline, Inc.
  • Filterlex Medical Ltd.
  • Inari Medical, Inc.
  • InspireMD Inc.
  • Invamed
  • Keystone Heart US, Inc. by Venus Medtech（Hangzhou）Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • NIPRO CORPORATION
  • Penumbra, Inc.
  • Protembis GmbH
  • Silk Road Medical, Inc.
  • Stryker Corporation
  • Terumo Medical Corporation
  • Transverse Medical Inc.
  • WL Gore & Associates, Inc.
Product Code: MRR-8958E923A6B8

The Embolic Protection Devices Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.86 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 2.98 billion by 2030.

Embolic protection devices (EPDs) are critical in interventional cardiovascular procedures, designed to capture and remove debris that dislodges during procedures such as percutaneous coronary interventions (PCIs) and transcatheter aortic valve replacements (TAVRs). Their necessity stems from the need to prevent embolism, a major complication that can lead to strokes or myocardial infarctions. These devices find applications in various procedures, primarily focusing on the cardiovascular system, with end-use markets extending to hospitals, cardiac centers, and ambulatory surgical units. The growth of the EPD market is influenced by the increasing prevalence of cardiovascular diseases and a heightened preference for minimally invasive surgical techniques. Additionally, technological advancements in device design, such as improving patient safety and procedural efficacy, further drive the market. Notable opportunities lie in emerging markets where healthcare infrastructure is experiencing robust development, alongside an increasing number of skilled professionals and patient awareness regarding cardiovascular health. However, the market faces limitations such as high costs of devices, regulatory hurdles, and the need for skilled personnel to operate these advanced technologies efficiently. Challenges include intense competition and reimbursement issues which can impede market penetration. Innovation should focus on integrating artificial intelligence and machine learning to enhance device functionality and patient outcomes, as well as developing reusable and cost-effective devices to broaden accessibility. Exploring partnerships or collaborations with research institutions can also foster innovative solutions. The EPD market's nature is dynamic, driven by constant technological advancements and evolving clinical needs. Companies that can adapt to these changes and focus on patient-centered solutions, while addressing regulatory and cost constraints, stand to strengthen their market position and drive significant business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.72 billion
Estimated Year [2024] USD 1.86 billion
Forecast Year [2030] USD 2.98 billion
CAGR (%) 8.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Embolic Protection Devices Market

The Embolic Protection Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of cardiovascular diseases and heart issues
    • Growing government initiatives to raise awareness for heart health and improve diagnosis of heart conditions
    • Expansion of surgical centers and involvement of clinics in research studies for embolic protection devices
  • Market Restraints
    • Incidences of product recall of embolic protection devices or systems
  • Market Opportunities
    • Ongoing innovations to improve functionality, safety, and efficiency of embolic protection devices
    • Regulatory approvals and support for authorization of embolic protection devices
  • Market Challenges
    • Performance issues and technical complexity of embolic protection devices

Porter's Five Forces: A Strategic Tool for Navigating the Embolic Protection Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Embolic Protection Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Embolic Protection Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Embolic Protection Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Embolic Protection Devices Market

A detailed market share analysis in the Embolic Protection Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Embolic Protection Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Embolic Protection Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Embolic Protection Devices Market

A strategic analysis of the Embolic Protection Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolic Protection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Balton Sp. z o. o., Boston Scientific Corporation, Contego Medical, Inc., Cook Group Incorporated, Cordis, Edwards Lifesciences Corporation, Emboline, Inc., Filterlex Medical Ltd., Inari Medical, Inc., InspireMD Inc., Invamed, Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NIPRO CORPORATION, Penumbra, Inc., Protembis GmbH, Silk Road Medical, Inc., Stryker Corporation, Terumo Medical Corporation, Transverse Medical Inc., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Embolic Protection Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Distal Filters, Distal Occlusion Devices, and Proximal Occlusion Devices.
  • Based on Application, market is studied across Cardiovascular Procedures and Neurovascular Procedures.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of cardiovascular diseases and heart issues
      • 5.1.1.2. Growing government initiatives to raise awareness for heart health and improve diagnosis of heart conditions
      • 5.1.1.3. Expansion of surgical centers and involvement of clinics in research studies for embolic protection devices
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall of embolic protection devices or systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve functionality, safety, and efficiency of embolic protection devices
      • 5.1.3.2. Regulatory approvals and support for authorization of embolic protection devices
    • 5.1.4. Challenges
      • 5.1.4.1. Performance issues and technical complexity of embolic protection devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Emerging adoption of distal filters owing to their flexibility, effectiveness, and minimally invasive nature
    • 5.2.2. Application: Expanding need for embolic protection devices to manage the large volume of cardiovascular interventions and surgeries
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Embolic Protection Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Distal Filters
  • 6.3. Distal Occlusion Devices
  • 6.4. Proximal Occlusion Devices

7. Embolic Protection Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Procedures
  • 7.3. Neurovascular Procedures

8. Embolic Protection Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Embolic Protection Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Embolic Protection Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Embolic Protection Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Protembis GmbH Secures USD 32.47 Million in Series B Funding to Accelerate the PROTEMBO Cerebral Protection Trial
    • 12.3.2. AorticLab Achieves CE Mark Approval for Innovative FLOWer Embolic Protection Device
    • 12.3.3. EnCompass Technologies Achieves Milestone with FDA Approval for F2 Cerebral Protection System Study
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AngioDynamics, Inc.
  • 3. Balton Sp. z o. o.
  • 4. Boston Scientific Corporation
  • 5. Contego Medical, Inc.
  • 6. Cook Group Incorporated
  • 7. Cordis
  • 8. Edwards Lifesciences Corporation
  • 9. Emboline, Inc.
  • 10. Filterlex Medical Ltd.
  • 11. Inari Medical, Inc.
  • 12. InspireMD Inc.
  • 13. Invamed
  • 14. Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc.
  • 15. Medtronic PLC
  • 16. Meril Life Sciences Pvt. Ltd.
  • 17. MicroPort Scientific Corporation
  • 18. NIPRO CORPORATION
  • 19. Penumbra, Inc.
  • 20. Protembis GmbH
  • 21. Silk Road Medical, Inc.
  • 22. Stryker Corporation
  • 23. Terumo Medical Corporation
  • 24. Transverse Medical Inc.
  • 25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. EMBOLIC PROTECTION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. EMBOLIC PROTECTION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EMBOLIC PROTECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. EMBOLIC PROTECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMBOLIC PROTECTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMBOLIC PROTECTION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIOVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EMBOLIC PROTECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. EMBOLIC PROTECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023